Spain – Antineoplastic agents – Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabt
HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL awarded €1.8M to HORI-HORI, S.A. for Construction & Public Works in January 2026 — one of 245 awards this buyer has made, above its typical award size.
Buying agency
HOSPITAL UNIVERSITARIO RAMÓN Y CAJALWinning supplier
HORI-HORI, S.A.Contract description
Spain – Antineoplastic agents – Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabtagen Vicleucel), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal
Related awards · HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
245 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-728689-2024EIFFAGE ENERGÍA, S.L.U.€11.8M29 Nov 2024 Construction
- ocds-ted-809184-2025JANSSEN CILAG, S.A.€2.8M05 Dec 2025 Construction
- ocds-ted-431556-2026HORI-HORI, S.A.€2.8M24 Jun 2026 Construction
Other wins · HORI-HORI, S.A.
7,817 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-304612-2025Dirección General de la Mutualidad de Funcionarios Civiles del Estado (MUFACE)€2.4B13 May 2025 Professional Services
- ocds-ted-268838-2026AGENCIA DE SEGURIDAD Y GESTIÓN INTEGRAL DE EMERGENCIAS DE ANDALUCIA€516M20 Apr 2026 Construction
- ocds-ted-641850-2025Junta de Gobierno del Ayuntamiento de Castellón de la Plana€339M01 Oct 2025 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL and HORI-HORI, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back